4147.TWO - TaiMed Biologics Inc.

Taipei Exchange - Taipei Exchange Delayed Price. Currency in TWD
Currency in TWD

Valuation Measures

Market Cap (intraday) 5
32.91B
Enterprise Value 3
31.29B
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
53.90
Price/Book (mrq)
8.99
Enterprise Value/Revenue 3
51.24
Enterprise Value/EBITDA 6
-73.77

Trading Information

Stock Price History

Beta (3Y Monthly) -0.13
52-Week Change 3-9.34%
S&P500 52-Week Change 315.09%
52 Week High 3189.50
52 Week Low 3130.00
50-Day Moving Average 3138.32
200-Day Moving Average 3147.37

Share Statistics

Avg Vol (3 month) 3988k
Avg Vol (10 day) 31.54M
Shares Outstanding 5252.18M
Float N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -106.47%
Operating Margin (ttm)-83.50%

Management Effectiveness

Return on Assets (ttm)-6.52%
Return on Equity (ttm)-16.52%

Income Statement

Revenue (ttm)610.6M
Revenue Per Share (ttm)2.43
Quarterly Revenue Growth (yoy)141.90%
Gross Profit (ttm)162.23M
EBITDA -424.12M
Net Income Avi to Common (ttm)-650.1M
Diluted EPS (ttm)-2.59
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.67B
Total Cash Per Share (mrq)6.63
Total Debt (mrq)34.45M
Total Debt/Equity (mrq)0.94
Current Ratio (mrq)4.48
Book Value Per Share (mrq)14.52

Cash Flow Statement

Operating Cash Flow (ttm)-459M
Levered Free Cash Flow (ttm)-726.72M